GENERATING TUMOR-SELECTIVE CONDITIONALLY ACTIVE BIOLOGIC ANTI-CTLA4 ANTIBODIES VIA PROTEIN-ASSOCIATED CHEMICAL SWITCHES

    |  

Recent publication by our co-founder and chairman, Jay Short, that discussing the mechanism he developed that enables our product candidates to be conditionally active around cancer cells.

View PDF

View LinkedIn post